nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—CYP1A1—chronic obstructive pulmonary disease	0.285	0.509	CbGaD
Daunorubicin—CYP1A2—chronic obstructive pulmonary disease	0.275	0.491	CbGaD
Daunorubicin—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0283	0.209	CbGbCtD
Daunorubicin—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.023	0.17	CbGbCtD
Daunorubicin—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0156	0.115	CbGbCtD
Daunorubicin—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0148	0.11	CbGbCtD
Daunorubicin—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0132	0.0978	CbGbCtD
Daunorubicin—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.013	0.0958	CbGbCtD
Daunorubicin—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0122	0.0904	CbGbCtD
Daunorubicin—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00776	0.0574	CbGbCtD
Daunorubicin—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00733	0.0542	CbGbCtD
Daunorubicin—YWHAG—respiratory system—chronic obstructive pulmonary disease	0.00218	0.0487	CbGeAlD
Daunorubicin—TOP2B—respiratory system—chronic obstructive pulmonary disease	0.0021	0.047	CbGeAlD
Daunorubicin—ABCC6—connective tissue—chronic obstructive pulmonary disease	0.00204	0.0456	CbGeAlD
Daunorubicin—YWHAG—connective tissue—chronic obstructive pulmonary disease	0.00192	0.0429	CbGeAlD
Daunorubicin—TOP2B—connective tissue—chronic obstructive pulmonary disease	0.00185	0.0413	CbGeAlD
Daunorubicin—YWHAG—bronchus—chronic obstructive pulmonary disease	0.00179	0.0401	CbGeAlD
Daunorubicin—Doxorubicin—NOS3—chronic obstructive pulmonary disease	0.00178	0.509	CrCbGaD
Daunorubicin—YWHAG—smooth muscle tissue—chronic obstructive pulmonary disease	0.00176	0.0392	CbGeAlD
Daunorubicin—TOP2B—bronchus—chronic obstructive pulmonary disease	0.00173	0.0387	CbGeAlD
Daunorubicin—TOP2A—Salmeterol—Salbutamol—chronic obstructive pulmonary disease	0.00173	0.807	CbGdCrCtD
Daunorubicin—Doxorubicin—NOS2—chronic obstructive pulmonary disease	0.00172	0.491	CrCbGaD
Daunorubicin—TOP2B—smooth muscle tissue—chronic obstructive pulmonary disease	0.00169	0.0378	CbGeAlD
Daunorubicin—POR—respiratory system—chronic obstructive pulmonary disease	0.00166	0.0371	CbGeAlD
Daunorubicin—YWHAG—trachea—chronic obstructive pulmonary disease	0.00161	0.036	CbGeAlD
Daunorubicin—TOP2B—trachea—chronic obstructive pulmonary disease	0.00155	0.0347	CbGeAlD
Daunorubicin—POR—bronchus—chronic obstructive pulmonary disease	0.00136	0.0305	CbGeAlD
Daunorubicin—TOP2A—bronchus—chronic obstructive pulmonary disease	0.00127	0.0284	CbGeAlD
Daunorubicin—ABCC6—lung—chronic obstructive pulmonary disease	0.00123	0.0275	CbGeAlD
Daunorubicin—POR—trachea—chronic obstructive pulmonary disease	0.00123	0.0274	CbGeAlD
Daunorubicin—YWHAG—lung—chronic obstructive pulmonary disease	0.00116	0.0259	CbGeAlD
Daunorubicin—TOP2B—lung—chronic obstructive pulmonary disease	0.00112	0.0249	CbGeAlD
Daunorubicin—ABCC10—bronchus—chronic obstructive pulmonary disease	0.00108	0.0242	CbGeAlD
Daunorubicin—CYP1B1—respiratory system—chronic obstructive pulmonary disease	0.00103	0.0231	CbGeAlD
Daunorubicin—ABCC10—trachea—chronic obstructive pulmonary disease	0.000972	0.0217	CbGeAlD
Daunorubicin—CYP1B1—connective tissue—chronic obstructive pulmonary disease	0.000911	0.0203	CbGeAlD
Daunorubicin—POR—lung—chronic obstructive pulmonary disease	0.00088	0.0197	CbGeAlD
Daunorubicin—CYP1B1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000833	0.0186	CbGeAlD
Daunorubicin—TOP2A—lung—chronic obstructive pulmonary disease	0.00082	0.0183	CbGeAlD
Daunorubicin—ABCC1—bronchus—chronic obstructive pulmonary disease	0.000766	0.0171	CbGeAlD
Daunorubicin—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000741	0.0166	CbGeAlD
Daunorubicin—CYP1A1—respiratory system—chronic obstructive pulmonary disease	0.000731	0.0163	CbGeAlD
Daunorubicin—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000715	0.016	CbGeAlD
Daunorubicin—ABCC10—lung—chronic obstructive pulmonary disease	0.000698	0.0156	CbGeAlD
Daunorubicin—ABCC1—trachea—chronic obstructive pulmonary disease	0.000688	0.0154	CbGeAlD
Daunorubicin—CYP1A1—bronchus—chronic obstructive pulmonary disease	0.000602	0.0134	CbGeAlD
Daunorubicin—CYP1B1—lung—chronic obstructive pulmonary disease	0.000549	0.0123	CbGeAlD
Daunorubicin—CYP1A1—trachea—chronic obstructive pulmonary disease	0.00054	0.0121	CbGeAlD
Daunorubicin—ABCC1—lung—chronic obstructive pulmonary disease	0.000494	0.011	CbGeAlD
Daunorubicin—ABCG2—lung—chronic obstructive pulmonary disease	0.000409	0.00914	CbGeAlD
Daunorubicin—CYP1A2—lung—chronic obstructive pulmonary disease	0.000394	0.0088	CbGeAlD
Daunorubicin—CYP1A1—lung—chronic obstructive pulmonary disease	0.000388	0.00868	CbGeAlD
Daunorubicin—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.00038	0.00849	CbGeAlD
Daunorubicin—CYP3A5—lung—chronic obstructive pulmonary disease	0.00038	0.00848	CbGeAlD
Daunorubicin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000283	0.00167	CcSEcCtD
Daunorubicin—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000283	0.00167	CcSEcCtD
Daunorubicin—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000283	0.00167	CcSEcCtD
Daunorubicin—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000283	0.00167	CcSEcCtD
Daunorubicin—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000283	0.00167	CcSEcCtD
Daunorubicin—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000283	0.00167	CcSEcCtD
Daunorubicin—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000283	0.00167	CcSEcCtD
Daunorubicin—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000283	0.00167	CcSEcCtD
Daunorubicin—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000282	0.00166	CcSEcCtD
Daunorubicin—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000282	0.00166	CcSEcCtD
Daunorubicin—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.00166	CcSEcCtD
Daunorubicin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000281	0.00166	CcSEcCtD
Daunorubicin—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000281	0.00166	CcSEcCtD
Daunorubicin—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.00166	CcSEcCtD
Daunorubicin—ABCB1—trachea—chronic obstructive pulmonary disease	0.000281	0.00627	CbGeAlD
Daunorubicin—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.000281	0.00165	CcSEcCtD
Daunorubicin—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000279	0.00165	CcSEcCtD
Daunorubicin—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000279	0.00165	CcSEcCtD
Daunorubicin—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000277	0.00163	CcSEcCtD
Daunorubicin—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000277	0.00163	CcSEcCtD
Daunorubicin—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000277	0.00163	CcSEcCtD
Daunorubicin—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000276	0.00163	CcSEcCtD
Daunorubicin—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000276	0.00163	CcSEcCtD
Daunorubicin—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000276	0.00163	CcSEcCtD
Daunorubicin—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000275	0.00162	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000275	0.00162	CcSEcCtD
Daunorubicin—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000274	0.00161	CcSEcCtD
Daunorubicin—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000274	0.00161	CcSEcCtD
Daunorubicin—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000273	0.00161	CcSEcCtD
Daunorubicin—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000271	0.0016	CcSEcCtD
Daunorubicin—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000271	0.0016	CcSEcCtD
Daunorubicin—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000271	0.0016	CcSEcCtD
Daunorubicin—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000271	0.0016	CcSEcCtD
Daunorubicin—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.0016	CcSEcCtD
Daunorubicin—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000269	0.00159	CcSEcCtD
Daunorubicin—Infection—Formoterol—chronic obstructive pulmonary disease	0.000269	0.00159	CcSEcCtD
Daunorubicin—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.00157	CcSEcCtD
Daunorubicin—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.00157	CcSEcCtD
Daunorubicin—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.00157	CcSEcCtD
Daunorubicin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000267	0.00157	CcSEcCtD
Daunorubicin—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00157	CcSEcCtD
Daunorubicin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000265	0.00156	CcSEcCtD
Daunorubicin—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000265	0.00156	CcSEcCtD
Daunorubicin—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000265	0.00156	CcSEcCtD
Daunorubicin—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000264	0.00156	CcSEcCtD
Daunorubicin—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000264	0.00156	CcSEcCtD
Daunorubicin—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000264	0.00155	CcSEcCtD
Daunorubicin—Infection—Montelukast—chronic obstructive pulmonary disease	0.000264	0.00155	CcSEcCtD
Daunorubicin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000262	0.00155	CcSEcCtD
Daunorubicin—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000261	0.00154	CcSEcCtD
Daunorubicin—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000261	0.00154	CcSEcCtD
Daunorubicin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00026	0.00153	CcSEcCtD
Daunorubicin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00151	CcSEcCtD
Daunorubicin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00151	CcSEcCtD
Daunorubicin—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.0015	CcSEcCtD
Daunorubicin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000252	0.00149	CcSEcCtD
Daunorubicin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000252	0.00148	CcSEcCtD
Daunorubicin—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000251	0.00148	CcSEcCtD
Daunorubicin—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000251	0.00148	CcSEcCtD
Daunorubicin—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.00147	CcSEcCtD
Daunorubicin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000247	0.00146	CcSEcCtD
Daunorubicin—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.00146	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000247	0.00146	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000247	0.00146	CcSEcCtD
Daunorubicin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000245	0.00144	CcSEcCtD
Daunorubicin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000245	0.00144	CcSEcCtD
Daunorubicin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.00144	CcSEcCtD
Daunorubicin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000244	0.00144	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000242	0.00143	CcSEcCtD
Daunorubicin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000242	0.00142	CcSEcCtD
Daunorubicin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000242	0.00142	CcSEcCtD
Daunorubicin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000241	0.00142	CcSEcCtD
Daunorubicin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000241	0.00142	CcSEcCtD
Daunorubicin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00024	0.00142	CcSEcCtD
Daunorubicin—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000239	0.00141	CcSEcCtD
Daunorubicin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000238	0.0014	CcSEcCtD
Daunorubicin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000236	0.00139	CcSEcCtD
Daunorubicin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000235	0.00139	CcSEcCtD
Daunorubicin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000234	0.00138	CcSEcCtD
Daunorubicin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000234	0.00138	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.00137	CcSEcCtD
Daunorubicin—Pain—Formoterol—chronic obstructive pulmonary disease	0.000232	0.00137	CcSEcCtD
Daunorubicin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000232	0.00137	CcSEcCtD
Daunorubicin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000232	0.00137	CcSEcCtD
Daunorubicin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000232	0.00137	CcSEcCtD
Daunorubicin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000231	0.00136	CcSEcCtD
Daunorubicin—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000231	0.00136	CcSEcCtD
Daunorubicin—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000231	0.00136	CcSEcCtD
Daunorubicin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000229	0.00135	CcSEcCtD
Daunorubicin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000228	0.00134	CcSEcCtD
Daunorubicin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000227	0.00134	CcSEcCtD
Daunorubicin—Pain—Montelukast—chronic obstructive pulmonary disease	0.000227	0.00134	CcSEcCtD
Daunorubicin—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000227	0.00134	CcSEcCtD
Daunorubicin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000226	0.00133	CcSEcCtD
Daunorubicin—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000226	0.00133	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000226	0.00133	CcSEcCtD
Daunorubicin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000224	0.00132	CcSEcCtD
Daunorubicin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000224	0.00132	CcSEcCtD
Daunorubicin—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000224	0.00132	CcSEcCtD
Daunorubicin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.00132	CcSEcCtD
Daunorubicin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000223	0.00132	CcSEcCtD
Daunorubicin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000223	0.00132	CcSEcCtD
Daunorubicin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.00131	CcSEcCtD
Daunorubicin—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000222	0.00131	CcSEcCtD
Daunorubicin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000222	0.00131	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000222	0.00131	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000222	0.00131	CcSEcCtD
Daunorubicin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.0013	CcSEcCtD
Daunorubicin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.00129	CcSEcCtD
Daunorubicin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.00129	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000217	0.00128	CcSEcCtD
Daunorubicin—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000217	0.00128	CcSEcCtD
Daunorubicin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000215	0.00127	CcSEcCtD
Daunorubicin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000215	0.00127	CcSEcCtD
Daunorubicin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00126	CcSEcCtD
Daunorubicin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00126	CcSEcCtD
Daunorubicin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00126	CcSEcCtD
Daunorubicin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00126	CcSEcCtD
Daunorubicin—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000214	0.00126	CcSEcCtD
Daunorubicin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000213	0.00126	CcSEcCtD
Daunorubicin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000212	0.00125	CcSEcCtD
Daunorubicin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000211	0.00125	CcSEcCtD
Daunorubicin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000211	0.00125	CcSEcCtD
Daunorubicin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000211	0.00124	CcSEcCtD
Daunorubicin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.00124	CcSEcCtD
Daunorubicin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00021	0.00124	CcSEcCtD
Daunorubicin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00021	0.00124	CcSEcCtD
Daunorubicin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00021	0.00124	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.00123	CcSEcCtD
Daunorubicin—TOP2A—Methyltestosterone—Prednisone—chronic obstructive pulmonary disease	0.000209	0.0975	CbGdCrCtD
Daunorubicin—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000206	0.00122	CcSEcCtD
Daunorubicin—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000206	0.00121	CcSEcCtD
Daunorubicin—TOP2A—Methyltestosterone—Prednisolone—chronic obstructive pulmonary disease	0.000204	0.0952	CbGdCrCtD
Daunorubicin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000203	0.0012	CcSEcCtD
Daunorubicin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00119	CcSEcCtD
Daunorubicin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00119	CcSEcCtD
Daunorubicin—ABCB1—lung—chronic obstructive pulmonary disease	0.000202	0.00451	CbGeAlD
Daunorubicin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.0002	0.00118	CcSEcCtD
Daunorubicin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.00118	CcSEcCtD
Daunorubicin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000199	0.00118	CcSEcCtD
Daunorubicin—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000199	0.00117	CcSEcCtD
Daunorubicin—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000199	0.00117	CcSEcCtD
Daunorubicin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00115	CcSEcCtD
Daunorubicin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000194	0.00115	CcSEcCtD
Daunorubicin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000194	0.00115	CcSEcCtD
Daunorubicin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000192	0.00113	CcSEcCtD
Daunorubicin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000192	0.00113	CcSEcCtD
Daunorubicin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00019	0.00112	CcSEcCtD
Daunorubicin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.00111	CcSEcCtD
Daunorubicin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000188	0.00111	CcSEcCtD
Daunorubicin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000185	0.00109	CcSEcCtD
Daunorubicin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000185	0.00109	CcSEcCtD
Daunorubicin—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.00109	CcSEcCtD
Daunorubicin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00108	CcSEcCtD
Daunorubicin—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000183	0.00108	CcSEcCtD
Daunorubicin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000182	0.00107	CcSEcCtD
Daunorubicin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.00107	CcSEcCtD
Daunorubicin—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00018	0.00106	CcSEcCtD
Daunorubicin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.00106	CcSEcCtD
Daunorubicin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000179	0.00106	CcSEcCtD
Daunorubicin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000175	0.00103	CcSEcCtD
Daunorubicin—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000175	0.00103	CcSEcCtD
Daunorubicin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.00103	CcSEcCtD
Daunorubicin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000172	0.00102	CcSEcCtD
Daunorubicin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000172	0.00102	CcSEcCtD
Daunorubicin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.00101	CcSEcCtD
Daunorubicin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000171	0.00101	CcSEcCtD
Daunorubicin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.00101	CcSEcCtD
Daunorubicin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000171	0.00101	CcSEcCtD
Daunorubicin—Headache—Formoterol—chronic obstructive pulmonary disease	0.00017	0.001	CcSEcCtD
Daunorubicin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00017	0.001	CcSEcCtD
Daunorubicin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.000998	CcSEcCtD
Daunorubicin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000169	0.000995	CcSEcCtD
Daunorubicin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000167	0.000987	CcSEcCtD
Daunorubicin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000167	0.000986	CcSEcCtD
Daunorubicin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.000984	CcSEcCtD
Daunorubicin—Depression—Prednisone—chronic obstructive pulmonary disease	0.000167	0.000983	CcSEcCtD
Daunorubicin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000166	0.00098	CcSEcCtD
Daunorubicin—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000972	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000966	CcSEcCtD
Daunorubicin—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000966	CcSEcCtD
Daunorubicin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.000959	CcSEcCtD
Daunorubicin—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000162	0.000956	CcSEcCtD
Daunorubicin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.000951	CcSEcCtD
Daunorubicin—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.000951	CcSEcCtD
Daunorubicin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.00095	CcSEcCtD
Daunorubicin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000161	0.000949	CcSEcCtD
Daunorubicin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.000949	CcSEcCtD
Daunorubicin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.000945	CcSEcCtD
Daunorubicin—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000158	0.000932	CcSEcCtD
Daunorubicin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000158	0.000929	CcSEcCtD
Daunorubicin—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.000919	CcSEcCtD
Daunorubicin—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.000915	CcSEcCtD
Daunorubicin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.000896	CcSEcCtD
Daunorubicin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.000892	CcSEcCtD
Daunorubicin—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000881	CcSEcCtD
Daunorubicin—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000147	0.000865	CcSEcCtD
Daunorubicin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000147	0.000865	CcSEcCtD
Daunorubicin—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.000851	CcSEcCtD
Daunorubicin—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000143	0.000844	CcSEcCtD
Daunorubicin—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.000836	CcSEcCtD
Daunorubicin—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000821	CcSEcCtD
Daunorubicin—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000791	CcSEcCtD
Daunorubicin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.000783	CcSEcCtD
Daunorubicin—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000782	CcSEcCtD
Daunorubicin—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000131	0.00077	CcSEcCtD
Daunorubicin—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.00074	CcSEcCtD
Daunorubicin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000715	CcSEcCtD
Daunorubicin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.000713	CcSEcCtD
Daunorubicin—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000712	CcSEcCtD
Daunorubicin—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000708	CcSEcCtD
Daunorubicin—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000695	CcSEcCtD
Daunorubicin—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000691	CcSEcCtD
Daunorubicin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000687	CcSEcCtD
Daunorubicin—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000677	CcSEcCtD
Daunorubicin—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000667	CcSEcCtD
Daunorubicin—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000665	CcSEcCtD
Daunorubicin—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000656	CcSEcCtD
Daunorubicin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000656	CcSEcCtD
Daunorubicin—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000654	CcSEcCtD
Daunorubicin—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000648	CcSEcCtD
Daunorubicin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000637	CcSEcCtD
Daunorubicin—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000629	CcSEcCtD
Daunorubicin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000629	CcSEcCtD
Daunorubicin—Infection—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000625	CcSEcCtD
Daunorubicin—Shock—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000619	CcSEcCtD
Daunorubicin—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000614	CcSEcCtD
Daunorubicin—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000608	CcSEcCtD
Daunorubicin—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000599	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	9.71e-05	0.000573	CcSEcCtD
Daunorubicin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	9.7e-05	0.000572	CcSEcCtD
Daunorubicin—Insomnia—Prednisone—chronic obstructive pulmonary disease	9.64e-05	0.000569	CcSEcCtD
Daunorubicin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	9.27e-05	0.000547	CcSEcCtD
Daunorubicin—Rash—Prednisolone—chronic obstructive pulmonary disease	9.25e-05	0.000546	CcSEcCtD
Daunorubicin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	9.24e-05	0.000545	CcSEcCtD
Daunorubicin—Fatigue—Prednisone—chronic obstructive pulmonary disease	9.19e-05	0.000542	CcSEcCtD
Daunorubicin—Headache—Prednisolone—chronic obstructive pulmonary disease	9.19e-05	0.000542	CcSEcCtD
Daunorubicin—Constipation—Prednisone—chronic obstructive pulmonary disease	9.12e-05	0.000538	CcSEcCtD
Daunorubicin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	8.79e-05	0.000518	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	8.72e-05	0.000514	CcSEcCtD
Daunorubicin—Nausea—Prednisolone—chronic obstructive pulmonary disease	8.72e-05	0.000514	CcSEcCtD
Daunorubicin—Urticaria—Prednisone—chronic obstructive pulmonary disease	8.47e-05	0.000499	CcSEcCtD
Daunorubicin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	8.43e-05	0.000497	CcSEcCtD
Daunorubicin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	8.43e-05	0.000497	CcSEcCtD
Daunorubicin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	7.86e-05	0.000463	CcSEcCtD
Daunorubicin—Asthenia—Prednisone—chronic obstructive pulmonary disease	7.65e-05	0.000451	CcSEcCtD
Daunorubicin—Pruritus—Prednisone—chronic obstructive pulmonary disease	7.54e-05	0.000445	CcSEcCtD
Daunorubicin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	7.3e-05	0.00043	CcSEcCtD
Daunorubicin—Dizziness—Prednisone—chronic obstructive pulmonary disease	7.05e-05	0.000416	CcSEcCtD
Daunorubicin—Vomiting—Prednisone—chronic obstructive pulmonary disease	6.78e-05	0.0004	CcSEcCtD
Daunorubicin—Rash—Prednisone—chronic obstructive pulmonary disease	6.72e-05	0.000396	CcSEcCtD
Daunorubicin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	6.72e-05	0.000396	CcSEcCtD
Daunorubicin—Headache—Prednisone—chronic obstructive pulmonary disease	6.68e-05	0.000394	CcSEcCtD
Daunorubicin—Nausea—Prednisone—chronic obstructive pulmonary disease	6.33e-05	0.000373	CcSEcCtD
Daunorubicin—ABCB11—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.05e-05	0.00072	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—APIP—chronic obstructive pulmonary disease	6.03e-05	0.000718	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6e-05	0.000714	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—APIP—chronic obstructive pulmonary disease	5.97e-05	0.000711	CbGpPWpGaD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	5.94e-05	0.000707	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.91e-05	0.000703	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—GC—chronic obstructive pulmonary disease	5.88e-05	0.0007	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	5.85e-05	0.000697	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	5.85e-05	0.000697	CbGpPWpGaD
Daunorubicin—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	5.84e-05	0.000695	CbGpPWpGaD
Daunorubicin—CYP1A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.83e-05	0.000693	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	5.83e-05	0.000693	CbGpPWpGaD
Daunorubicin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.8e-05	0.00069	CbGpPWpGaD
Daunorubicin—CYP1A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.75e-05	0.000684	CbGpPWpGaD
Daunorubicin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.73e-05	0.000681	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—EGFR—chronic obstructive pulmonary disease	5.71e-05	0.00068	CbGpPWpGaD
Daunorubicin—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.67e-05	0.000675	CbGpPWpGaD
Daunorubicin—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.59e-05	0.000665	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.47e-05	0.000651	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—TNF—chronic obstructive pulmonary disease	5.44e-05	0.000647	CbGpPWpGaD
Daunorubicin—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.37e-05	0.000639	CbGpPWpGaD
Daunorubicin—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.36e-05	0.000638	CbGpPWpGaD
Daunorubicin—CYP1A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.36e-05	0.000637	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	5.31e-05	0.000631	CbGpPWpGaD
Daunorubicin—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.3e-05	0.000631	CbGpPWpGaD
Daunorubicin—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.3e-05	0.000631	CbGpPWpGaD
Daunorubicin—CYP1A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.28e-05	0.000629	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	5.14e-05	0.000612	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.89e-05	0.000582	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.87e-05	0.000579	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.77e-05	0.000568	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.73e-05	0.000563	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	4.72e-05	0.000562	CbGpPWpGaD
Daunorubicin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.7e-05	0.00056	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.55e-05	0.000541	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.54e-05	0.000541	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.5e-05	0.000536	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GC—chronic obstructive pulmonary disease	4.42e-05	0.000526	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.39e-05	0.000523	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—IL6—chronic obstructive pulmonary disease	4.39e-05	0.000522	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.36e-05	0.000519	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	4.36e-05	0.000519	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.36e-05	0.000518	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.36e-05	0.000518	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.36e-05	0.000518	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	4.32e-05	0.000514	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—GCLC—chronic obstructive pulmonary disease	4.31e-05	0.000513	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GC—chronic obstructive pulmonary disease	4.27e-05	0.000509	CbGpPWpGaD
Daunorubicin—ABCC2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	4.23e-05	0.000503	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	4.18e-05	0.000497	CbGpPWpGaD
Daunorubicin—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.14e-05	0.000492	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.11e-05	0.000489	CbGpPWpGaD
Daunorubicin—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.09e-05	0.000487	CbGpPWpGaD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	4.09e-05	0.000486	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—APIP—chronic obstructive pulmonary disease	4.08e-05	0.000486	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.01e-05	0.000477	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4e-05	0.000476	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4e-05	0.000476	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.97e-05	0.000473	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.96e-05	0.000471	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—CTGF—chronic obstructive pulmonary disease	3.93e-05	0.000468	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.92e-05	0.000466	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.92e-05	0.000466	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	3.89e-05	0.000463	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GC—chronic obstructive pulmonary disease	3.85e-05	0.000458	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	3.85e-05	0.000458	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.77e-05	0.000448	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.73e-05	0.000444	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.73e-05	0.000444	CbGpPWpGaD
Daunorubicin—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.72e-05	0.000442	CbGpPWpGaD
Daunorubicin—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.67e-05	0.000436	CbGpPWpGaD
Daunorubicin—SLC22A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.63e-05	0.000431	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.62e-05	0.000431	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.61e-05	0.00043	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.58e-05	0.000426	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.57e-05	0.000424	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	3.54e-05	0.000421	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.52e-05	0.000419	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	3.52e-05	0.000419	CbGpPWpGaD
Daunorubicin—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.44e-05	0.000409	CbGpPWpGaD
Daunorubicin—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.41e-05	0.000406	CbGpPWpGaD
Daunorubicin—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.39e-05	0.000404	CbGpPWpGaD
Daunorubicin—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.37e-05	0.000401	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.27e-05	0.000389	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	3.26e-05	0.000388	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	3.25e-05	0.000387	CbGpPWpGaD
Daunorubicin—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.24e-05	0.000385	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.21e-05	0.000382	CbGpPWpGaD
Daunorubicin—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.19e-05	0.00038	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—GCLC—chronic obstructive pulmonary disease	3.18e-05	0.000378	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.17e-05	0.000377	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.1e-05	0.000369	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.07e-05	0.000365	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	3.03e-05	0.000361	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.02e-05	0.00036	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.98e-05	0.000355	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.96e-05	0.000352	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.91e-05	0.000347	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—CTGF—chronic obstructive pulmonary disease	2.9e-05	0.000345	CbGpPWpGaD
Daunorubicin—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.87e-05	0.000341	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.86e-05	0.000341	CbGpPWpGaD
Daunorubicin—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.83e-05	0.000337	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	2.79e-05	0.000332	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.78e-05	0.00033	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.71e-05	0.000322	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.68e-05	0.000319	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.67e-05	0.000318	CbGpPWpGaD
Daunorubicin—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.64e-05	0.000314	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	2.63e-05	0.000313	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.63e-05	0.000313	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.6e-05	0.00031	CbGpPWpGaD
Daunorubicin—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.6e-05	0.000309	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.59e-05	0.000308	CbGpPWpGaD
Daunorubicin—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.5e-05	0.000297	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—TP53—chronic obstructive pulmonary disease	2.48e-05	0.000295	CbGpPWpGaD
Daunorubicin—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.46e-05	0.000293	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.45e-05	0.000291	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HDAC2—chronic obstructive pulmonary disease	2.42e-05	0.000288	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.41e-05	0.000287	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.39e-05	0.000284	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.33e-05	0.000278	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.31e-05	0.000275	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—KL—chronic obstructive pulmonary disease	2.25e-05	0.000268	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.23e-05	0.000265	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.22e-05	0.000265	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.2e-05	0.000261	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.18e-05	0.000259	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.16e-05	0.000257	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.15e-05	0.000256	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.14e-05	0.000255	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.12e-05	0.000253	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.12e-05	0.000252	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.11e-05	0.000251	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.1e-05	0.00025	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.1e-05	0.00025	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.1e-05	0.00025	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.08e-05	0.000247	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.05e-05	0.000244	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.01e-05	0.000239	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.01e-05	0.000239	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.95e-05	0.000233	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.94e-05	0.000231	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.94e-05	0.000231	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.92e-05	0.000228	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.9e-05	0.000226	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.86e-05	0.000222	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.86e-05	0.000221	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.84e-05	0.000219	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—ALB—chronic obstructive pulmonary disease	1.79e-05	0.000213	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.77e-05	0.00021	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.75e-05	0.000208	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.75e-05	0.000208	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—TP53—chronic obstructive pulmonary disease	1.74e-05	0.000206	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.73e-05	0.000205	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—NOS3—chronic obstructive pulmonary disease	1.71e-05	0.000204	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—ERBB3—chronic obstructive pulmonary disease	1.69e-05	0.000201	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.68e-05	0.0002	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.68e-05	0.000199	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.67e-05	0.000199	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.65e-05	0.000196	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.62e-05	0.000193	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.6e-05	0.000191	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.6e-05	0.00019	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.57e-05	0.000187	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.56e-05	0.000186	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.54e-05	0.000183	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.52e-05	0.000181	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.5e-05	0.000179	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.5e-05	0.000178	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.49e-05	0.000177	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.47e-05	0.000175	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.46e-05	0.000173	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.46e-05	0.000173	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.45e-05	0.000173	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.44e-05	0.000171	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.44e-05	0.000171	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.42e-05	0.000169	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.41e-05	0.000168	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—NOS2—chronic obstructive pulmonary disease	1.41e-05	0.000168	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.37e-05	0.000163	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.35e-05	0.000161	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.34e-05	0.000159	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.33e-05	0.000158	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.33e-05	0.000158	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.32e-05	0.000157	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—ALB—chronic obstructive pulmonary disease	1.32e-05	0.000157	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.3e-05	0.000154	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.3e-05	0.000154	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.28e-05	0.000153	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.27e-05	0.000151	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.26e-05	0.000151	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—NOS3—chronic obstructive pulmonary disease	1.26e-05	0.00015	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.24e-05	0.000148	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.2e-05	0.000143	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.2e-05	0.000142	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SERPINE1—chronic obstructive pulmonary disease	1.19e-05	0.000141	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.15e-05	0.000137	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.14e-05	0.000135	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—NOS3—chronic obstructive pulmonary disease	1.13e-05	0.000135	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.05e-05	0.000126	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.04e-05	0.000124	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.04e-05	0.000123	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.01e-05	0.00012	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.97e-06	0.000119	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—ALB—chronic obstructive pulmonary disease	9.91e-06	0.000118	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.83e-06	0.000117	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.69e-06	0.000115	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—ALB—chronic obstructive pulmonary disease	9.58e-06	0.000114	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.54e-06	0.000114	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.48e-06	0.000113	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.19e-06	0.000109	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.17e-06	0.000109	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.17e-06	0.000109	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.16e-06	0.000109	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	9.06e-06	0.000108	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	8.72e-06	0.000104	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	8.63e-06	0.000103	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.45e-06	0.000101	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	8.34e-06	9.92e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	8.27e-06	9.84e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	8.25e-06	9.82e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.96e-06	9.47e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.85e-06	9.34e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TGFB1—chronic obstructive pulmonary disease	7.48e-06	8.9e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—EGFR—chronic obstructive pulmonary disease	7.34e-06	8.73e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.32e-06	8.7e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.08e-06	8.42e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.99e-06	8.32e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.94e-06	8.25e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.38e-06	7.59e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.36e-06	7.56e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.27e-06	7.46e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	6.25e-06	7.43e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	5.98e-06	7.11e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	5.9e-06	7.02e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.88e-06	7e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.84e-06	6.95e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.65e-06	6.72e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—IL6—chronic obstructive pulmonary disease	5.64e-06	6.71e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.54e-06	6.59e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.9e-06	5.84e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.84e-06	5.76e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	4.71e-06	5.61e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.51e-06	5.37e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.51e-06	5.36e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.27e-06	5.08e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.76e-06	4.48e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.6e-06	4.28e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.9e-06	3.46e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.78e-06	3.31e-05	CbGpPWpGaD
